Table of Contents Author Guidelines Submit a Manuscript
Journal of Obesity
Volume 2015, Article ID 178526, 6 pages
http://dx.doi.org/10.1155/2015/178526
Research Article

Obesity and Metabolic Phenotypes (Metabolically Healthy and Unhealthy Variants) Are Significantly Associated with Prevalence of Elevated C-Reactive Protein and Hepatic Steatosis in a Large Healthy Brazilian Population

1Aventura Hospital and Medical Center, Aventura, FL 33180, USA
2Center for Prevention and Wellness Research, Baptist Health South Florida, Miami, FL 33139, USA
3Department of Epidemiology, Robert Stempel College of Public Health, Florida International University, Miami, FL 33199, USA
4Johns Hopkins Ciccarone Center for Preventive Cardiology, Johns Hopkins University, Baltimore, MD 21287, USA
5Preventive Medicine Center, Avenida Albert Einstein 627/701, 05652-900 Morumbi, SP, Brazil
6Heart Institute (InCor) University of São Paulo Medical School Hospital & Preventive Medicine Center, Hospital Israelita Albert Einstein, 05652-900 São Paulo, SP, Brazil
7Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA

Received 3 December 2014; Accepted 19 February 2015

Academic Editor: R. Prager

Copyright © 2015 Sameer Shaharyar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. G. Solomon and J. E. Manson, “Obesity and mortality: a review of the epidemiologic data,” The American Journal of Clinical Nutrition, vol. 66, supplement 4, pp. 1044S–1050S, 1997. View at Google Scholar
  2. S. Velho, F. Paccaud, G. Waeber, P. Vollenweider, and P. Marques-Vidal, “Metabolically healthy obesity: different prevalences using different criteria,” European Journal of Clinical Nutrition, vol. 64, no. 10, pp. 1043–1051, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Blüher, “The distinction of metabolically ‘healthy’ from ‘unhealthy’ obese individuals,” Current Opinion in Lipidology, vol. 21, no. 1, pp. 38–43, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. A. D. Karelis, “Obesity: to be obese—does it matter if you are metabolically healthy?” Nature Reviews Endocrinology, vol. 7, no. 12, pp. 699–700, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. P. T. Katzmarzyk, I. Janssen, R. Ross, T. S. Church, and S. N. Blair, “The importance of waist circumference in the definition of metabolic syndrome: prospective analyses of mortality in men,” Diabetes Care, vol. 29, no. 2, pp. 404–409, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. K. E. Kip, O. C. Marroquin, D. E. Kelley et al., “Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women’s Ischemia Syndrome Evaluation (WISE) study,” Circulation, vol. 109, no. 6, pp. 706–713, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Song, J. E. Manson, J. B. Meigs, P. M. Ridker, J. E. Buring, and S. Liu, “Comparison of usefulness of body mass index versus metabolic risk factors in predicting 10-year risk of cardiovascular events in women,” The American Journal of Cardiology, vol. 100, no. 11, pp. 1654–1658, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. J. B. Meigs, P. W. F. Wilson, C. S. Fox et al., “Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 8, pp. 2906–2912, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. A. C. St-Pierre, B. Cantin, P. Mauriège et al., “Insulin resistance syndrome, body mass index and the risk of ischemic heart disease,” Canadian Medical Association Journal, vol. 172, no. 10, pp. 1301–1305, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Calori, G. Lattuada, L. Piemonti et al., “Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the cremona study,” Diabetes Care, vol. 34, no. 1, pp. 210–215, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. A. D. Ogorodnikova, M. Kim, A. P. McGinn, P. Muntner, U. Khan, and R. P. Wildman, “Incident cardiovascular disease events in metabolically benign obese individuals,” Obesity, vol. 20, no. 3, pp. 651–659, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Ärnlöv, E. Ingelsson, J. Sundström, and L. Lind, “Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men,” Circulation, vol. 121, no. 2, pp. 230–236, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. A. J. Flint, F. B. Hu, R. J. Glynn et al., “Excess weight and the risk of incident coronary heart disease among men and women,” Obesity, vol. 18, no. 2, pp. 377–383, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. R. V. Dvorak, W. F. DeNino, P. A. Ades, and E. T. Poehlman, “Phenotypic characteristics associated with insulin resistance in metabolically obese but normal-weight young women,” Diabetes, vol. 48, no. 11, pp. 2210–2214, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Bellentani, G. Saccoccio, F. Masutti et al., “Prevalence of and risk factors for hepatic steatosis in northern Italy,” Annals of Internal Medicine, vol. 132, no. 2, pp. 112–117, 2000. View at Google Scholar · View at Scopus
  16. P. L. Huang, “A comprehensive definition for metabolic syndrome,” Disease Models & Mechanisms, vol. 2, no. 5-6, pp. 231–237, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. R. S. Ahima and J. S. Flier, “Adipose tissue as an endocrine organ,” Trends in Endocrinology and Metabolism, vol. 11, no. 8, pp. 327–332, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. T. H. Lee, W. S. Jeon, K. J. Han et al., “Comparison of serum adipocytokine levels according to metabolic health and obesity status,” Endocrinology and Metabolism. In press.
  19. H. Oflaz, N. Ozbey, F. Mantar et al., “Determination of endothelial function and early atherosclerotic changes in healthy obese women,” Diabetes, Nutrition and Metabolism: Clinical and Experimental, vol. 16, no. 3, pp. 176–181, 2003. View at Google Scholar · View at Scopus
  20. M. A. Marini, E. Succurro, S. Frontoni et al., “Metabolically healthy but obese women have an intermediate cardiovascular risk profile between healthy nonobese women and obese insulin-resistant women,” Diabetes Care, vol. 30, no. 8, pp. 2145–2147, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. C. H. Jung, M. J. Lee, J. Y. Hwang et al., “Association of metabolically healthy obesity (MHO) with subclinical coronary atherosclerosis in a Korean population,” Obesity, vol. 22, no. 12, pp. 2613–2620, 2014. View at Publisher · View at Google Scholar
  22. R. Eshtiaghi, S. Keihani, F. Hosseinpanah, M. Barzin, and F. Azizi, “Natural course of metabolically healthy abdominal obese adults after 10 years of follow-up: the Tehran Lipid and Glucose Study,” International Journal of Obesity, 2014. View at Publisher · View at Google Scholar
  23. L. L. Roberson, E. C. Aneni, W. Maziak et al., “Beyond BMI: the ‘metabolically healthy obese’ phenotype & its association with clinical/subclinical cardiovascular disease and all-cause mortality—a systematic review,” BMC Public Health, vol. 14, no. 1, article 14, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Seppälä-Lindroos, S. Vehkavaara, A.-M. Häkkinen et al., “Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 7, pp. 3023–3028, 2002. View at Google Scholar · View at Scopus